ARCHIVES

NCI Director’s Office Gets Makeover In Reorganization Plan.

This article is from The Cancer Letter archive.

Vol. 32 No. 44 | December 8, 2006

Download PDF Visit The Full Archive

Related Articles

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995

Braun Named Executive Director Of ASCO Foundation

November 17, 2006

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

ACCC Asks More Community Representation, Clear Separation From Centers In New NCI Division

June 29, 1979